COLLABORATIONS |
1 |
Dept. of Endocrinology, St. Bartholomew’s Hospital,
University of London UK |
2 |
The Clayton Foundation Laboratories for Peptide
Biology. The Salk Institute, La Jolla, CA, USA |
3 |
Dept. of Anaesthesiology, Neuroanesthesia Research,
University of Illinois at Chicago, USA |
4 |
Laboratory of Pharmacology, Faculty of Pharmaceutical
Sciences of Ribeirão Preto, University of São Paulo,
Brazil |
|
PUBLICATIONS |
1 |
Tringali G, Pozzoli G, Vairano M, Mores N,
Preziosi P, Navarra P. (2005) Interleukin-18 displays effects opposite
to those of interleukin-1 in the regulation of neuroendocrine stress
axis. J Neuroimmunol. 160: 61-67. |
2 |
Fabricio ASC, Tringali G, Pozzoli G and Navarra
P. (2005) Mirtazapine acutely inhibits basal and K+-stimulated release
of corticotropin-releasing hormone from the rat hypothalamus via
a non-genomic mechanism. Psychopharmacology 178: 78-82. |
3 |
Fabricio A, Veiga F, Cristofoletti R, Navarra
P, Souza G. (2005) The effects of selective and non-selective cyclooxygenase
inhibitors on endothelin-1-induced fever in rats. Am. J. Physiol.
288: R671-677. |
4 |
Palozza P, Serini S, Maggiano N, Tringali G,
Navarra P, Ranelletti FO, Calviello G. (2005) beta-Carotene downregulates
the steady-state and heregulin-alpha-induced COX-2 pathways in colon
cancer cells. J Nutr 135:129-136. |
5 |
Calviello G, Di Nicuolo F, Gragnoli S, Piccioni
E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza
P. (2004) n-3 PUFAs reduce VEGF expression in human colon cancer
cells modulating the COX-2/ PGE2 induced ERK-1 and -2 and HIF-1{alpha}
induction pathway. Carcinogenesis 25: 2303-2310. |
6 |
Tringali G, Aubry JM, Moscianese K, Zamori
C, Vairano M, Preziosi P, Navarra P and Pozzoli G. (2004) Valproic
acid inhibits corticotropin releasing factor (CRF) synthesis and
release from the rat hypothalamus in vitro: evidence for the involvement
of GABA-ergic neurotransmission. J Psychiatry Neurosci 29: 459-466. |
7 |
Vairano M, Graziani G,
Tentori L, Tringali G, Navarra P
and Dello Russo C. (2004) Primary cultures of microglial
cells for testing toxicity of anticancer drugs. Toxicol Lett 148:
911-914. |
|